Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors
dc.contributor.author | Laha, Joydev K. | |
dc.contributor.author | Zhang, Xuemei | |
dc.contributor.author | Qiao, Lixin | |
dc.contributor.author | Chatterjee, Snigdha | |
dc.contributor.author | Robinson, Shaughnessy | |
dc.contributor.author | Kosik, Kenneth S. | |
dc.contributor.author | Cuny, Gregory D. | |
dc.date.accessioned | 2020-03-10T17:31:37Z | |
dc.date.available | 2020-03-10T17:31:37Z | |
dc.date.issued | 2012-04 | |
dc.description.abstract | Cdk5/p25 has emerged as a principle therapeutic target for numerous acute and chronic neurodegenerative diseases, including Alzheimer’s disease. A structure–activity relationship study of 2,4-diaminothiazole inhibitors revealed that increased Cdk5/p25 inhibitory activity could be accomplished by incorporating pyridines on the 2-amino group and addition of substituents to the 2- or 3-position of the phenyl ketone moiety. Interpretation of the SAR results for many of the analogs was aided through in silico docking with Cdk5/p25 and calculating protein hydrations sites using WaterMap. Finally, improved in vitro mouse microsomal stability was also achieved. | |
dc.identifier.citation | Copyright 2011 Bioorganic and Medicinal Chemistry Letters. This is a post-print version of a published paper that is available at: https://www.sciencedirect.com/science/article/pii/S0960894X11001740. Recommended citation: Laha, Joydev K., Xuemei Zhang, Lixin Qiao, Min Liu, Snigdha Chatterjee, Shaughnessy Robinson, Kenneth S. Kosik, and Gregory D. Cuny. "Structure–activity relationship study of 2, 4-diaminothiazoles as Cdk5/p25 kinase inhibitors." Bioorganic & medicinal chemistry letters 21, no. 7 (2011): 2098-2101. doi: 10.1016/j.bmcl.2011.01.140. This item has been deposited in accordance with publisher copyright and licensing terms and with the author's permission. | |
dc.identifier.uri | https://hdl.handle.net/10657/5959 | |
dc.language.iso | en_US | |
dc.publisher | Bioorganic and Medicinal Chemistry Letters | |
dc.subject | Cdk5 | |
dc.subject | Kinase | |
dc.subject | Inhibitor | |
dc.subject | Alzheimer's disease | |
dc.subject | 2,4-diaminothiazoles | |
dc.title | Structure–activity relationship study of 2,4-diaminothiazoles as Cdk5/p25 kinase inhibitors | |
dc.type | Article |